Sarah B. Fisher, Kevin E. Fisher, Sameer H. Patel, Matthew G. Lim, David A. Kooby, Bassel F. El-Rayes, Charles A. Staley III, N. Volkan Adsay, Alton B. Farris III and Shishir K. Maithel Excision repair cross-complementing gene-1, ribonucleotide reductase subunit M1, ribonucleotide reductase subunit M2, and human equilibrative nucleoside transporter-1 expression and prognostic value in biliary tract malignancy Cancer 119
Version of Record online: 3 JUL 2012 | DOI: 10.1002/cncr.27739
High tumor expression of ribonucleotide reductase subunit 2 (RRM2) or human equilibrative nucleoside transporter 1 (hENT1) is associated with reduced survival after resection of biliary tract malignancy. These biomarkers should be considered when selecting patients for adjuvant treatment and stratifying patients who are enrolled in clinical trials.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field